Biochips enable the accurate, rapid, and high-throughput detection of DNA, RNA, polypeptides, proteins, cells, tissues, and other biological components, with great advantages in disease screening and early diagnosis.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

PerkinElmer Genomics has chosen BioDiscoverys NxClinical software for genomic data analysis for its services, BioDiscovery announced recently . The software will enable PerkinElmer Genomics to provide fast and accurate copy number variation

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology co

Danaher today reported a 7 percent year-over-year increase in its third quarter revenues with its diagnostic revenues up 3 percent. For the three months ended Sept. 28, 2018, the Washington-based conglomerate tallied $4.85 billion in total r

Agena Biosciences and DaRui Biotechnology announced today that Agenas MassArray system has been cleared by the China Food and Drug Administration. The system is a mass spectrometry-based platform that Agena acquired from Sequenom in 2014 for

The global hemostasis/coagulation analyzers market was valued at USD 3.65 billion in 2017 and is expected to grow at a CAGR of 9.9% over the period 2018 to 2026 to reach USD 9.55 billion by 2026, driven mainly by the growing incidence of blo

A clinical assay from Zeesan Biotech to detect and identify 14 high-risk genotypes of human papillomavirus has been approved by the China State Food and Drug Administration, company announced recently. The MeltPro High Risk HPV test, which w

The global medical gas analyzers market was valued at USD 235 million in 2017 and is expected to grow at a CAGR of 4.1% from 2018 to 2025 to reach USD 325 million by 2025, driven by an upsurge in the adoption of medical gas analyzers, string

BioMrieux reported today that its third quarter revenues grew 7 percent year over year driven in part by strong growth in its molecular biology clinical applications. For the three months ended Sept. 30, the Marcy ltoile, France-based in vit

An estimated 100 million-plus people , roughly one-third of the U.S. population, will have had their DNA analyzed using an at-home genetic test kit by 2021. Up to 60% of the time, identified genetic variants are going to be proven correct wi

When it comes toin vitrodiagnostic (IVD) technologies, medical device and diagnostic companies have been chomping at the bit to produce the next big innovation. The last few years have seen a surge in IVD technologies in the market, as devic